Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties

References

• Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med 2018;378:1537–34.
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683–92.
   PubMed Web of Science ®Google Scholar
• Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000;9:2395–402.
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012;150:12–27.
   PubMed Web of Science ®Google Scholar
• Chuang JC, Yoo CB, Kwan JM, et al. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine. Mol Cancer Ther 2005;4:1515–20.
   PubMed Web of Science ®Google Scholar
• Takemura Y, Satoh M, Hatanaka K, et al. Zebularine exerts its antiproliferative activity through s phase delay and cell death in human malignant mesothelioma cells. Biosci Biotechnol Biochem 2018;82:1159–64.
   PubMed Web of Science ®Google Scholar
• Kuang YT, El-Khoueiry A, Taverna P, et al. Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin. Mol Oncol 2015;9:1799–814.
   PubMed Web of Science ®Google Scholar
• Seidel C, Florean C, Schnekenburger M, et al. Chromatin-modifying agents in anti-cancer therapy. Biochimie 2012;94:2264–79.
   PubMed Web of Science ®Google Scholar
• Fang MZ, Chen DP, Sun Y, et al. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005;11:7033–42.
   PubMed Web of Science ®Google Scholar
• Fang MZ, Wang YM, Ai N, et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563–70.
   PubMed Web of Science ®Google Scholar
• Dikmen M. Comparison of the effects of curcumin and RG108 on NGF-induced PC-12 Adh cell differentiation and neurite outgrowth. J Med Food 2017;20:376–85.
   PubMed Web of Science ®Google Scholar
• Zambrano P, Segura-Pachero B, Perez-Cardenas E, et al. A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer 2005;5:44.
   PubMed Web of Science ®Google Scholar
• Cornacchia E, Golbus J, Maybaum J, et al. Hydralazine and procainamide inhibit T-cell DNA methylation and induce autoreactivity. J Immunol 1988;140:2197–200.
   PubMed Web of Science ®Google Scholar
• Castellano S, Kuck D, Viviano M, et al. Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors. J Med Chem 2011;54:7663–77.
   PubMed Web of Science ®Google Scholar
• Asgatay S, Champion C, Marloie G, et al. Synthesis and evaluation of analogues of N-phthaloyl-L-tryptophan (RG108) as inhibitors of DNA methyltransferase 1. J Med Chem 2014;57:421–34.
   PubMed Web of Science ®Google Scholar
• Datta J, Ghoshal K, Denny WA, et al. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. Cancer Res 2009;69:4277–85.
   PubMed Web of Science ®Google Scholar
• Gilmartin AG, Groy A, Core ER, et al. In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor. Haematologica 2020;106:1979–87.
   Web of Science ®Google Scholar
• Juarez-Mercado KE, Prieto-Martinez FD, Sanchez-Cruz N, et al. Expanding the structural diversity of DNA methyltransferase inhibitors. Pharmaceuticals 2020;14:17.
   Web of Science ®Google Scholar
• Pechalrieu D, Dauzonne D, Arimondo PB, et al. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells. Eur J Med Chem 2020;186:111829.
   PubMed Web of Science ®Google Scholar
• Chen SJ, Wang YL, Zhou W, et al. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening. J Med Chem 2014;57:9028–41.
   PubMed Web of Science ®Google Scholar
• Bedford RB, Betham M. N-H carbazole synthesis from 2-chloroanilines via consecutive amination and C-H activation. J Org Chem 2006;71:8.
   Web of Science ®Google Scholar
• Molette J, Routier J, Abla N, et al. Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties. ACS Med Chem Lett 2013;4:1037–41.
   PubMed Web of Science ®Google Scholar
• Bombrun A, Gerber P, Casi G, et al. 3,6-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulation. J Med Chem 2003;46:4.
   Web of Science ®Google Scholar
• Svedruzic ZM. Mammalian cytosine DNA methyltransferase DNMT1: enzymatic mechanism, novel mechanism-based inhibitors, and RNA-directed DNA methylation. Curr Med Chem 2008;15:92–106.
   PubMed Web of Science ®Google Scholar
• Song JK, Teplova M, Ishibe-Murakami S, et al. Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation. Science 2012;335:709–12.
   PubMed Web of Science ®Google Scholar
• Egger G, Liang GN, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429:457–63.
   PubMed Web of Science ®Google Scholar
• Huang X, Yan J, Zhang M, et al. Targeting epigenetic crosstalk as a for EZH2-aberrant solid tumors. Cell 2018;175:186–34.
   PubMed Web of Science ®Google Scholar
• Meier K, Brehm A. Chromatin regulation: how complex does it get? Epigenetics 2014;9:1485–95.
   PubMed Web of Science ®Google Scholar
• Milner CM, Campbell RD. The G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeats. Biochem J 1993; 290:811–8.
   PubMed Web of Science ®Google Scholar
• Esteller M. Molecular origins of cancer: epigenetics in cancer. N Engl J Med 2008;358:1148–59.
   PubMed Web of Science ®Google Scholar
• Rivera CM, Ren B. Mapping human epigenomes. Cell 2013;155:39–55.
   PubMed Web of Science ®Google Scholar
• Yoo J, Medina-Franco JL. Inhibitors of DNA methyltransferases: insights from computational studies. Curr Med Chem 2012;19:3475–87.
   PubMed Web of Science ®Google Scholar
• Wei WL, An YL, Li ZW, et al. Simultaneous determination of resibufogenin and its eight metabolites in rat plasma by LC-MS/MS for metabolic profiles and pharmacokinetic study. Phytomedicine 2019;60:152971.
   PubMed Web of Science ®Google Scholar
• Estève PO, Chin HG, Smallwood A, et al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 2006;20:3089–103.
   PubMed Web of Science ®Google Scholar
• Fu JL, Zhou HX, Chen J, et al. Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF-α. Oncol Rep 2020;44:1616–26.
   PubMed Web of Science ®Google Scholar
• Xiao DL, Dasgupta C, Chen M, et al. Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats. Cardiovasc Res 2014;101:373–82.
   PubMed Web of Science ®Google Scholar